Literature DB >> 31576298

Profiling changes in metabolism and the immune microenvironment in lung tumorigenesis.

Di Zhang1, Ana S Leal1, Fawzi Abu Rous1, Karen T Liby1.   

Abstract

Year:  2019        PMID: 31576298      PMCID: PMC6685892          DOI: 10.21037/atm.2019.04.33

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  23 in total

1.  Nrf2 enhances cholangiocyte expansion in Pten-deficient livers.

Authors:  Keiko Taguchi; Ikuo Hirano; Tohru Itoh; Minoru Tanaka; Atsushi Miyajima; Akira Suzuki; Hozumi Motohashi; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2013-12-30       Impact factor: 4.272

Review 2.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

Review 3.  The lung microenvironment: an important regulator of tumour growth and metastasis.

Authors:  Nasser K Altorki; Geoffrey J Markowitz; Dingcheng Gao; Jeffrey L Port; Ashish Saxena; Brendon Stiles; Timothy McGraw; Vivek Mittal
Journal:  Nat Rev Cancer       Date:  2019-01       Impact factor: 60.716

Review 4.  Immune Checkpoint Inhibitors in the Management of Lung Cancer.

Authors:  Stefan Zimmermann; Solange Peters; Taofeek Owinokoko; Shirish M Gadgeel
Journal:  Am Soc Clin Oncol Educ Book       Date:  2018-05-23

Review 5.  Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases.

Authors:  Antonio Cuadrado; Ana I Rojo; Geoffrey Wells; John D Hayes; Sharon P Cousin; William L Rumsey; Otis C Attucks; Stephen Franklin; Anna-Liisa Levonen; Thomas W Kensler; Albena T Dinkova-Kostova
Journal:  Nat Rev Drug Discov       Date:  2019-04       Impact factor: 84.694

6.  Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer.

Authors:  Luis Paz-Ares; Alexander Luft; David Vicente; Ali Tafreshi; Mahmut Gümüş; Julien Mazières; Barbara Hermes; Filiz Çay Şenler; Tibor Csőszi; Andrea Fülöp; Jerónimo Rodríguez-Cid; Jonathan Wilson; Shunichi Sugawara; Terufumi Kato; Ki Hyeong Lee; Ying Cheng; Silvia Novello; Balazs Halmos; Xiaodong Li; Gregory M Lubiniecki; Bilal Piperdi; Dariusz M Kowalski
Journal:  N Engl J Med       Date:  2018-09-25       Impact factor: 91.245

7.  Identification of an Unfavorable Immune Signature in Advanced Lung Tumors from Nrf2-Deficient Mice.

Authors:  Di Zhang; Jonathan Rennhack; Eran R Andrechek; Cheryl E Rockwell; Karen T Liby
Journal:  Antioxid Redox Signal       Date:  2018-04-16       Impact factor: 8.401

8.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.

Authors:  Ethan Cerami; Jianjiong Gao; Ugur Dogrusoz; Benjamin E Gross; Selcuk Onur Sumer; Bülent Arman Aksoy; Anders Jacobsen; Caitlin J Byrne; Michael L Heuer; Erik Larsson; Yevgeniy Antipin; Boris Reva; Arthur P Goldberg; Chris Sander; Nikolaus Schultz
Journal:  Cancer Discov       Date:  2012-05       Impact factor: 39.397

9.  Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis.

Authors:  Gina M DeNicola; Florian A Karreth; Timothy J Humpton; Aarthi Gopinathan; Cong Wei; Kristopher Frese; Dipti Mangal; Kenneth H Yu; Charles J Yeo; Eric S Calhoun; Francesca Scrimieri; Jordan M Winter; Ralph H Hruban; Christine Iacobuzio-Donahue; Scott E Kern; Ian A Blair; David A Tuveson
Journal:  Nature       Date:  2011-07-06       Impact factor: 49.962

10.  NRF2 regulates serine biosynthesis in non-small cell lung cancer.

Authors:  Gina M DeNicola; Pei-Hsuan Chen; Edouard Mullarky; Jessica A Sudderth; Zeping Hu; David Wu; Hao Tang; Yang Xie; John M Asara; Kenneth E Huffman; Ignacio I Wistuba; John D Minna; Ralph J DeBerardinis; Lewis C Cantley
Journal:  Nat Genet       Date:  2015-10-19       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.